XLV241227C150000
- 0.04
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
Looking Into AbbVie's Recent Short Interest
Express News | Lilly's weight loss medication is now available for purchase on e-commerce platforms in China
$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today
UnitedHealth Group's Options Frenzy: What You Need to Know
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
BofA Reports $10B in U.S. Equity Inflows, Marking Largest Weekly Surge Since 2017
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Court Rules Enanta Patent Invalid in Pfizer Paxlovid Case; Appeal Planned
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Eli Lilly Stock Is Rising Monday: What's Going On?
Weekly ETF Flows: Seven Out of 11 Sectors Record Outflows; Bitcoin Continues to Lead With Higher Inflows
14 Analysts Have This To Say About Danaher
Unpacking the Latest Options Trading Trends in UnitedHealth Group
This Omeros Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
ResMed, Inspire Medical Fall After Lilly's Zepbound Gains Sleep Apnea Indication
2024's 'Biggest Loses' That Could See Reversal in 2025
Danaher Analyst Ratings
Thermo Fisher Scientific Analyst Ratings